your badges 52W Range $1–$3 3% of range Analyst Rating BUY 12 analysts Price Target $12 +1093% upside P/E -4.6 ROE 1488.8% Net Profit Margin -1786.3%

OCGN Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03
Price $1.02
Market Cap (MRQ) $346M
P/E -4.6
EPS $-0.26
Revenue $4M
ROE 1488.8%
Debt/Equity (MRQ) -0.1
52W Range $1–$3

OCGN Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04
range
bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

Stock splits 1
Ex-date Split Type
Sept. 30, 2019 1-for-60 Reverse

10-Year Performance Revenue, net income, margins and EPS trends

06
Revenue$4M
2022-12-31 → 2025-12-31
EPS$-0.26
2022-12-31 → 2023-12-31
Free Cash Flow$-57M
2022-12-31 → 2025-12-31
Net margin-1786.3%
2024-12-31 → 2025-12-31
Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric 5Y trend OCGN 5Y avg Peer Median Verdict
P/E -4.65Y avg ≈-3.7 ≈-3.7 · ·
P/S (TTM) 75.5 · 30.2 Overvalued
P/B (MRQ) -20.9 · · ·
EV / EBITDA -5.6 · · ·
Price / FCF (TTM) -5.7 · · ·
Price / Cash Flow (TTM) -5.7 · · ·
EV / Revenue 80.5 · · ·
EV / FCF -6.2 · · ·
Price / Tangible Book 6.5 · · ·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

value · ≈ 5Y avg · industry median · verdict relative to median

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

14
Avg Surprise -6.2%
Next Report Nov 03, 2026
PeriodReportEPS ActualEPS EstSurprise
June 30, 2026 Jul 30, 2026 $-0.07 $-0.05 -28.7%
March 31, 2026 May 7, 2026 $-0.06 $-0.05 -14.3%
Dec. 31, 2025 $-0.06 $-0.06 -1.4%
Sept. 30, 2025 $-0.07 $-0.06 -22.6%
June 30, 2025 $-0.05 $-0.06 14.8%
March 31, 2025 $-0.05 $-0.06 14.8%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15
Income Statement 16
Metric Trend 20252024202320222021202020192018201720162015
Revenue $4M$4M$6M$2M$0$43.0K$0$0$0$0$0
R&D Expense $40M$32M$40M···$8M$10M$16M$22M$23M
SG&A Expense $28M$27M$32M$35M$23M$8M$6M$6M$9M$9M$8M
Operating Expenses $67M$59M$72M$92M$58M$21M$14M$16M$25M$30M$32M
Operating Income $-63M$-55M$-66M$-89M$-58M$-21M$-14M$-16M$-25M$-30M$-32M
Interest Expense ····$79.0K$721.0K$2M$4M·$60.0K$133.0K
Interest Income $922.0K$1M···$1.1K$1.2K$19.2K···
Other Non-op $-664.0K$140.0K$2M$2M$-389.0K$184.0K$-784.0K$-12.4K$-116.0K$-248.0K$-72.0K
Pretax Income $-68M$-54M$-63M$-87M$-58M$-22M$-20M$-9M$-26M$-16M$-32M
Income Tax $0$0$0$0$-52.0K$0$0····
Net Income $-68M$-54M$-63M$-87M$-58M$-22M$-20M$-18M$-26M$-16M$-32M
EPS (Basic) ··$-0.26$-0.40$-0.30$-0.31$-1.46$-0.23$-0.99$-0.97$-2.42
EPS (Diluted) ··$-0.26$-0.40$-0.30$-0.31$-1.46$-0.79$-0.99$-2.18$-2.42
Shares (Basic) ··244,327,057214,600,051195,013,043112,236,11013,893,81936,398,45022,669,81914,256,95413,231,126
Shares (Diluted) ··244,327,057214,600,051195,013,043112,236,11013,893,81937,090,19722,669,81914,389,19213,231,126
EBITDA $-63M$-55M·$-84M$-58M$-21M·$-30M$-25M$-30M$-32M
Balance Sheet 27
Metric Trend 20252024202320222021202020192018201720162015
Cash & Equivalents $19M$59M$39M$78M$95M$24M$7M$2M$7M$32M$31M
Prepaid Expense $6M$3M$4M$8M$8M$2M$1M$313.5K$194.0K$173.0K$321.0K
Other Current Assets $439.0K$879.0K·····$172.0K$122.0K$68.0K$195.0K
Current Assets $24M$62M$43M$98M$103M$26M$16M$2M$8M$32M$31M
PP&E (Net) $14M$17M$17M$6M$1M$633.0K$222.5K$245.8K$3M$4M$5M
PP&E (Gross) $20M$20M$19M$7M$2M$859.0K$348.5K$10M$14M$13M$13M
Accum. Depreciation $6M$3M$1M$621.0K$374.0K$226.0K$126.0K$10M$11M$9M$8M
Intangibles ··········$200.0K
Other Non-current Assets $4M$4M$4M$4M$2M$714.0K$667.7K$116.3K···
Total Assets $44M$82M$65M$109M$106M$27M$17M$2M$11M$36M$37M
Accounts Payable $6M$4M$3M$8M$2M$395.0K$2M$3M$776.0K$2M$2M
Accrued Liabilities ···$10M$4M$3M$2M$1M$3M$2M$1M
Short-term Debt ····$0$234.0K$0$7M···
Current Liabilities $23M$22M$17M$29M$7M$4M$5M$14M$4M$5M$6M
Capital Leases $3M$3M$4M$4M$1M$389.0K$163.2K····
Other Non-current Liabilities $2M$564.0K$527.0K$244.0K$0$0$9.8K$37.5K···
Total Liabilities $56M$53M$24M$35M$10M$6M$6M$15M$22M$23M$9M
Long-term Debt $29M$29M$3M$2M$2M$2M$1M····
Total Debt $29M$29M·$2M$2M$2M·····
Common Stock $3M$3M$3M$2M$2M$2M$527.5K$49.6K$159.0K$159.0K$132.0K
Paid-in Capital $393M$367M$324M$295M$226M$93M$62M$18M···
Retained Earnings $-408M$-340M$-286M$-223M$-132M$-73M$-51M$31M$-208M$-182M$-166M
Treasury Stock $48.0K$48.0K$48.0K$48.0K$48.0K$48.0K$47.9K····
AOCI $61.0K$48.0K$20.0K$26.0K$0··$451···
Stockholders' Equity $-12M$30M$41M$74M$91M$22M$11M$-13M$4M$14M$28M
Liabilities + Equity $44M$82M$65M$109M$106M$27M$17M$2M$11M$36M$37M
Shares Outstanding 312,379,972291,489,058256,688,304221,721,182199,502,183184,011,88452,625,2284,960,55224,571,02920,647,61213,273,470
Cash Flow 16
Metric Trend 20252024202320222021202020192018201720162015
D&A ···$480.0K$229.0K······
Stock-based Comp ·······$2M$2M$2M$1M
Other Non-cash ···$21M·······
Operating Cash Flow $-57M$-42M$-62M$-60M$-48M$-15M$-17M$-12M$-23M$-26M$-30M
CapEx $185.0K$3M$10M$4M$939.0K$307.0K$30.0K$77.4K$276.0K$320.0K$2M
Investing Cash Flow $-311.0K$-3M$3M$-17M$-2M$-307.0K$-2M$-77.4K$-1M··
Debt Issued ···$500.0K$0······
Net Debt Issued ···$500.0K·······
Stock Issued $20M$39M$21M$60M$129M$38M$1M$0··$5M
Stock Repurchased ····$0$0$48.0K$0···
Net Stock Activity $20M$39M·$60M$129M$38M·$26M··$5M
Financing Cash Flow $17M$65M$21M$59M$121M$32M$25M$7M$-577.0K··
Net Change in Cash $-40M$19M$-38M$-18M$71M$17M$6M$-5M$-25M$993.0K$-28M
Taxes Paid ·······$105.0K$197.0K$257.0K$79.0K
Free Cash Flow $-57M$-46M·$-65M$-49M$-15M·$-18M$-23M$-26M$-32M
Levered FCF ····$-49M······
Profitability 7
Metric Trend 20252024202320222021202020192018201720162015
Operating Margin -1425.7%-1350.4%···-49940.7%·····
Net Margin -1537.4%-1333.0%···-51201.2%·····
Pretax Margin -1537.4%-1333.0%·········
EBITDA Margin -1425.7%-1350.4%···-49940.7%·····
ROA -107.7%-73.6%·-72.4%-87.7%-98.8%·-60.7%-112.1%-44.5%-62.6%
ROE 1488.8%-153.9%·-95.9%-57.5%-121.3%·229.3%-2297.9%-77.6%-77.7%
ROIC -378.4%-93.9%·-98.3%-59.4%······
Liquidity & Solvency 5
Metric Trend 20252024202320222021202020192018201720162015
Current Ratio 1.12.9·5.314.77.2·5.72.16.24.9
Quick Ratio 0.82.7·4.213.66.7·5.41.96.24.9
Debt / Equity -2.41.0·0.00.00.1·····
LT Debt / Equity -2.30.9·0.00.00.1·····
Interest Coverage ····-734.5-29.5···-505.1-239.2
Efficiency 1
Metric Trend 20252024202320222021202020192018201720162015
Asset Turnover 0.10.1··0.00.0·0.00.00.00.0
Per Share 5
Metric Trend 20252024202320222021202020192018201720162015
Book Value / Share $-0.04$0.10·$0.38$0.48$0.12·$-0.01$-0.46$0.66$2.12
Revenue / Share ····$0.00··$0.00$0.00$0.00·
Cash Flow / Share ···$-0.28$-0.25··$-0.43$-1.02$-1.79·
Cash / Share $0.06$0.20·$0.35$0.48$0.13·$0.25$0.29$1.55$2.33
EPS (TTM) $-0.24$-0.24$-0.26$-0.40$-0.30$-0.31$-1.46$-0.79$-0.99$-2.18$-2.42
Growth Rates 3
Metric Trend 20252024202320222021202020192018201720162015
Revenue YoY 8.8%-32.8%142.6%········
Revenue CAGR 3Y 21.1%·419.7%········
Revenue CAGR 5Y 152.5%··········
Valuation (TTM) 14
Metric Trend 20252024202320222021202020192018201720162015
Revenue TTM $4M$4M$6M$2M$0$43.0K$0$0$0$0$0
Net Income TTM $-68M$-54M$-63M$-87M$-58M$-22M$-20M$-18M$-26M$-16M$-32M
Market Cap $422M$235M·$288M$907M$337M·$327M$3.02B$2.07B$2.79B
Enterprise Value $432M$205M·$213M$814M$315M·····
P/E -5.6-3.4-2.2-3.2-15.2-5.9-0.4-6.7-124.2-46.0-86.8
P/S 95.657.8·115.8·7831.2·····
P/B -34.77.9·3.49.515.6·-715.1-268.2152.598.9
P / Tangible Book ·7.93.63.99.915.6·····
P / Cash Flow -7.4-5.6·-4.8-18.9-22.9·-20.8-131.3-80.4-92.8
P / FCF -7.4-5.2·-4.5-18.6-22.4·-18.4-129.7-79.4-87.2
EV / EBITDA -6.9-3.7·-2.5-14.0-14.8·····
EV / FCF -7.6-4.5·-3.3-16.7-21.0·····
EV / Revenue 97.950.5·85.5·7320.0·····
Earnings Yield -17.8%-29.8%-45.2%-30.8%-6.6%-16.9%-280.8%-15.0%-0.80%-2.2%-1.1%

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16
Metric 2025-12-312024-12-312023-12-312023-09-302023-06-30
Revenue $4M $4M $6M · ·
Operating Margin % -1425.7% -1350.4% · · ·
Net Income $-68M $-54M $-63M · ·
Diluted EPS · · $-0.26 · ·

Institutional owners (13F) 163 filers · $241.4M total · As of June 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 163
Value held $241.4M
New positions 43
Exited positions 29
Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
43 (-9 vs prior Q) 29 (+14 vs prior Q) 47 (+2 vs prior Q) 32 (+11 vs prior Q) +32.6M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
BlackRock, Inc. $41,314,488 27,002,933 17.12% Shares
STATE STREET CORP $32,848,040 21,469,307 13.61% Shares
VANGUARD GROUP INC $22,242,009 16,475,562 9.21% Shares
VANGUARD CAPITAL MANAGEMENT LLC $21,990,075 14,372,598 9.11% Shares
MILLENNIUM MANAGEMENT LLC $21,333,176 13,943,252 8.84% Shares
GEODE CAPITAL MANAGEMENT, LLC $13,576,029 8,871,013 5.62% Shares
RTW INVESTMENTS, LP $10,199,999 6,666,666 4.23% Shares
UBS Group AG $7,921,587 5,177,508 3.28% Shares
Ikarian Capital, LLC $6,063,348 3,962,972 2.51% Shares
GMT Capital Corp $5,363,259 3,505,398 2.22% Shares
MARSHALL WACE, LLP $5,217,694 3,410,257 2.16% Shares
VANGUARD PORTFOLIO MANAGEMENT LLC $5,094,052 3,329,446 2.11% Shares
NORTHERN TRUST CORP $4,203,771 2,747,562 1.74% Shares
VANGUARD FIDUCIARY TRUST CO $3,621,730 2,367,144 1.50% Shares
TWO SIGMA INVESTMENTS, LP $3,412,174 2,230,179 1.41% Shares
Qube Research & Technologies Ltd $3,371,213 2,203,407 1.40% Shares
BANK OF AMERICA CORP /DE/ $3,045,673 1,990,636 1.26% Shares
BOOTHBAY FUND MANAGEMENT, LLC $1,679,545 1,097,742 0.70% Shares
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $1,595,082 1,042,537 0.66% Shares
GOLDMAN SACHS GROUP INC $1,561,968 1,020,894 0.65% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $1,561,333 1,020,479 0.65% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $1,501,848 981,600 0.62% Call option
Nuveen, LLC $1,259,895 823,461 0.52% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $1,255,518 820,600 0.52% Put option
Bank of New York Mellon Corp $1,237,517 808,835 0.51% Shares
CITADEL ADVISORS LLC $1,198,483 783,322 0.50% Shares
CITIGROUP INC $839,345 548,591 0.35% Shares
Headlands Technologies LLC $782,710 511,575 0.32% Shares
Point72 Asset Management, L.P. $731,066 477,821 0.30% Shares
Procyon Advisors, LLC $674,329 440,738 0.28% Shares
MILLENNIUM MANAGEMENT LLC $650,250 425,000 0.27% Call option
Rafferty Asset Management, LLC $594,826 388,775 0.25% Shares
MORGAN STANLEY $574,755 375,656 0.24% Shares
BARCLAYS PLC $560,865 366,579 0.23% Shares
RHUMBLINE ADVISERS $520,946 340,493 0.22% Shares
DEUTSCHE BANK AG\ $516,995 337,905 0.21% Shares
WELLS FARGO & COMPANY/MN $490,545 320,617 0.20% Shares
OSAIC HOLDINGS, INC. $470,589 307,575 0.19% Shares
BNP PARIBAS FINANCIAL MARKETS $454,846 297,285 0.19% Shares
Voleon Capital Management LP $454,404 296,996 0.19% Shares
CITADEL ADVISORS LLC $391,221 255,700 0.16% Call option
SILVERBACK ASSET MANAGEMENT LLC $382,500 250,000 0.16% Shares
WELLINGTON MANAGEMENT GROUP LLP $372,708 243,600 0.15% Shares
NewEdge Advisors, LLC $362,885 237,180 0.15% Shares
TWO SIGMA ADVISERS, LP $361,125 267,500 0.15% Shares
Caption Management, LLC $344,250 225,000 0.14% Call option
ALLIANCEBERNSTEIN L.P. $323,773 178,880 0.13% Shares
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. $315,166 201,858 0.13% Shares
MetLife Investment Management, LLC $308,240 201,464 0.13% Shares
DIADEMA PARTNERS LP $306,000 200,000 0.13% Shares

Show all 163 institutional owners →

Activists & 5%+ owners 3 positions

18

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
Wilmslow Estates Limited ×5 filings Oct. 2, 2019 · Initial filing · SEC
Randal J. Kirk, Intrexon Corporation ×2 filings Jan. 15, 2019 · Initial filing · SEC
Split Rock Partners II, LP, Split Rock Partners II Management, LLC ×4 filings Jan. 3, 2019 · Initial filing · SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Company insiders 37 insiders · 18 officers · 20 directors

19
Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Shankar Musunuri Chief Executive Officer Sept. 9, 2026 S 1,088,035 0 2 $-589,110
Adam Gridley President and CEO Oct. 1, 2018 D 7,000 0 0 $0
Treerita Essalima Johnson-Greene Chief Financial Officer June 15, 2026 P 521,000 1 0 $25,830
Sanjay Subramanian Chief Financial Officer Jan. 3, 2022 A 161,125 0 0 $0
Jonathan I Lieber Chief Financial Officer Oct. 1, 2018 D 5,000 0 0 $0
Kevin Mcardle Chief Financial Officer Feb. 26, 2015 A · 0 0 $0
Stephen Richard Kennedy Chief Operating Officer Oct. 1, 2018 D · 0 0 $0
Ramesh Ramachandran Chief Accounting Officer Jan. 2, 2026 A 209,100 0 0 $0
Huma Qamar Chief Medical Officer Jan. 2, 2025 A · 0 0 $0
Arun Upadhyay Chief Scientific Officer, Head of Research, Development and Medical Jan. 2, 2025 A 306,197 0 0 $0
Jessica Crespo CAO/SVP, Finance Jan. 3, 2023 F 161,478 0 0 $0
Vijay Tammara Senior Vice President May 4, 2021 M 0 0 0 $0
Kelly Beck Vice President May 5, 2020 A · 0 0 $0
Rasappa Arumugham Chief Scientific Officer May 5, 2020 A · 0 0 $0
Daniel Jorgensen Chief Medical Officer May 5, 2020 A · 0 0 $0
Donald Haut Chief Business Officer Oct. 1, 2018 A · 0 0 $0
Lynne E Kelley Chief Medical Officer Oct. 1, 2018 A · 0 0 $0
Gloria Matthews Chief Medical Officer Feb. 14, 2017 A · 0 0 $0
Satishchandran Chandrasekhar Director June 11, 2026 A · 0 0 $0
Kirsten Castillo Director June 11, 2026 A 75,000 0 0 $0
Uday Kompella Director June 11, 2026 A 154,416 0 0 $0
Junge Zhang Director June 11, 2026 A 1,359,316 0 0 $0
Blaise Coleman Director June 11, 2026 A · 0 0 $0
Prabhavathi Fernandes Director Nov. 26, 2024 P 10,000 0 0 $0
Marna C Whittington Director June 28, 2024 A · 0 0 $0
Ramesh Kumar Director June 9, 2023 A 0 0 0 $0
Manish Potti Director Dec. 16, 2021 M 45,000 0 0 $0
Suha Taspolatoglu Director Jan. 1, 2021 A · 0 0 $0
Frank Leo Director Jan. 2, 2020 A · 0 0 $0
Michael Lewis Director Feb. 8, 2019 M 5,258,859 0 0 $0
Kevin Rakin Director Feb. 8, 2019 M 257,846 0 0 $0
Garheng Kong Director June 15, 2018 A · 0 0 $0
Joshua J Baltzell Director June 15, 2018 A · 0 0 $0
John Johnson Director June 15, 2018 A · 0 0 $0
David N Gill Director June 15, 2018 A 14,000 0 0 $0
Susan B. Washer Director April 16, 2018 A · 0 0 $0
Wilmslow Estates Ltd 10% owner Feb. 8, 2019 M 5,258,859 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

ETF ownership Held by 17 ETFs

20

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
IDNA · iShares Trust 0.33% 828,044 SH Sept. 11, 2026 Daily
LABU · Direxion Shares ETF Trust 0.12% 475,253 NS July 31, 2026 N-PORT
IWC · iShares Trust 0.08% 1,164,541 SH Sept. 11, 2026 Daily
PWS · Pacer Funds Trust 0.03% 6,493 NS July 31, 2026 N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS 0.02% 1,967,143 SH Aug. 19, 2026 Daily
VTWG · VANGUARD SCOTTSDALE FUNDS 0.02% 253,813 SH Aug. 19, 2026 Daily
IWO · iShares Trust 0.02% 2,209,874 SH Sept. 11, 2026 Daily
RSSL · Global X Funds 0.01% 162,573 NS July 31, 2026 N-PORT
IWM · iShares Trust 0.01% 8,750,491 SH Sept. 11, 2026 Daily
VXF · VANGUARD INDEX FUNDS 0.01% 3,881,633 SH Aug. 19, 2026 Daily
VTWV · VANGUARD SCOTTSDALE FUNDS 0.01% 92,513 SH Aug. 19, 2026 Daily
VHT · VANGUARD WORLD FUND 0.01% 987,168 SH Aug. 19, 2026 Daily
ITOT · iShares Trust 0.00% 666,585 SH Sept. 11, 2026 Daily
IWV · iShares Trust 0.00% 140,788 SH Sept. 10, 2026 Daily
VTI · VANGUARD INDEX FUNDS 0.00% 10,177,094 SH Aug. 19, 2026 Daily
VTHR · VANGUARD SCOTTSDALE FUNDS 0.00% 28,809 SH Aug. 19, 2026 Daily
IWN · iShares Trust · 990,640 SH Sept. 11, 2026 Daily

OCGN Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21
rating · 12 analysts BUY
Median target $10.50 +929.4%
3 25.0% Strong Buy
8 66.7% Buy
1 8.3% Hold
0 0.0% Sell
0 0.0% Strong Sell

12-Month Price Target

6 analysts · 2026-10-03

Mean target $12.17 +1092.8%

← Below all targets Current price $1.02
Low$8.00 Mean$12.17 High$22.00

Peer comparison (GICS sub-industry) Key metrics vs sector peers

22

FY basis, prices as of each company's last fiscal year-end close.

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
OCGN $422M -5.6 8.8% -1537.4% 1488.8% ·
CCCC $185M -1.5 1.0% -292.1% -48.8% ·
INDP $6M -0.1 · · -2820.8% ·
FENC $263M -22.6 -6.1% -21.8% -69.6% ·
ZNTL $93M -0.7 · · -49.5% ·
SRZN · · · · · ·
CYPH $97M 16.6 · · 6.1% ·
ARTV · -1.3 -99.2% · · ·
CABA $220M -1.0 · · -115.5% ·
EBS $644M 13.3 -28.8% 7.1% 9.9% ·
SCTX · · · · · ·

Latest News Recent headlines mentioning this company

23
Ocugen Inc. (OCGN): One of the Popular Penny Stocks on Robinhood Yahoo Finance · 6 months ago Oppenheimer Initiates Ocugen (OCGN) With a Buy Rating Yahoo Finance · 6 months, 1 week ago

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Source: SEC 10-Q filed Aug 6, 2026